An update from Dimerix Limited ( (AU:DXB) ) is now available.
Dimerix Limited has announced a correction to the Change of Director’s Interest Notice, revealing that Managing Director Nina Webster acquired 127,917 ordinary shares through the exercise of options. This correction ensures transparency in the company’s disclosures, potentially affecting stakeholder trust and market perceptions.
More about Dimerix Limited
Dimerix is a biopharmaceutical company focused on developing innovative therapies to address unmet medical needs.
YTD Price Performance: 27.94%
Average Trading Volume: 2,341,072
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: A$242.9M
For an in-depth examination of DXB stock, go to TipRanks’ Stock Analysis page.